2-(phenethylamino)-4-(4-methylpiperazin-1-yl)-1-nitrobenzene

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 2-(phenethylamino)-4-(4-methylpiperazin-1-yl)-1-nitrobenzene
• 英文别名: [5-(4-Methyl-piperazin-1-yl)-2-nitro-phenyl]-phenethyl-amine；5-(4-methylpiperazin-1-yl)-2-nitro-N-phenethylbenzenamine；5-(4-methylpiperazin-1-yl)-2-nitro-N-(2-phenylethyl)aniline
• 化学式: C₁₉H₂₄N₄O₂
• 分子量: 340.425
• InChiKey: DVVLFHJJRRSZPW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  64.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N-甲基哌嗪 、 N-(2-phenylethyl)-5-chloro-2-nitroaniline 生成 2-(phenethylamino)-4-(4-methylpiperazin-1-yl)-1-nitrobenzene
  参考文献：
  名称：

  Regular Trends in Nucleophilic Substitutions in 2-Alkylamino-4-chloronitrobenzenes

  摘要：

  研究了位置 2 上的取代基对 2-烷基氨基-4-氯硝基苯在不同性质的 N-亲核物亲核取代中的反应性的影响。

  DOI：

  10.1007/s11178-005-0146-6

文献信息

• [EN] BROAD-SPECTRUM INHIBITORS OF FILOVIRUSES<br/>[FR] INHIBITEURS À LARGE SPECTRE DE FILOVIRUS
  申请人：MICROBIOTIX INC

  公开号：WO2018106667A1

  公开（公告）日：2018-06-14

  The present invention is related to the development of therapeutics and prophylactics for the treatment and/or prevention of filovirus infection in humans and other mammals. A new class of small molecules is disclosed that inhibits the interaction of naturally processed (i.e., proteolytically cleaved) filovirus glycoprotein (GPCL) with its host receptor Niemann-Pick C 1 (NPCl) protein and thus block infection of host cells by filoviruses. Also disclosed are methods of using the small molecule inhibitors in the treatment/prevention of filovirus infection.

  本发明涉及开发用于治疗和/或预防人类和其他哺乳动物的Filovirus感染的治疗和预防剂。揭示了一类新的小分子，它抑制了自然加工（即蛋白酶水解）的Filovirus糖蛋白（GPCL）与其宿主受体Niemann-Pick C1（NPC1）蛋白的相互作用，从而阻止Filovirus感染宿主细胞。还揭示了在治疗/预防Filovirus感染中使用小分子抑制剂的方法。
• Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1902733A1

  公开（公告）日：2008-03-26

  The present invention relates to an active substance combination comprising at least one compound with 5-HT6 receptor affinity, and at least NMDA-receptor ligand, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.

  本发明涉及一种由至少一种具有 5-HT6 受体亲和力的化合物和至少一种 NMDA 受体配体组成的活性物质组合、一种包含所述活性物质组合的药物，以及使用所述活性物质组合制造药物。
• Broad spectrum inhibitors of filoviruses
  申请人：Microbiotix, Inc.

  公开号：US11459308B2

  公开（公告）日：2022-10-04

  The present invention is related to the development of therapeutics and prophylactics for the treatment and/or prevention of filovirus infection in humans and other mammals. A new class of small molecules is disclosed that inhibits the interaction of naturally processed (i.e., proteolytically cleaved) filovirus glycoprotein (GPCL) with its host receptor Niemann-Pick C1 (NPC1) protein and thus block infection of host cells by filoviruses. Also disclosed are methods of using the small molecule inhibitors in the treatment/prevention of filovirus infection.

  本发明涉及治疗和/或预防人类和其他哺乳动物丝状病毒感染的治疗剂和预防剂的开发。本发明公开了一类新的小分子化合物，可抑制天然加工（即蛋白水解）的丝状病毒糖蛋白（GPCL）与其宿主受体 Niemann-Pick C1（NPC1）蛋白的相互作用，从而阻断丝状病毒对宿主细胞的感染。还公开了使用小分子抑制剂治疗/预防丝状病毒感染的方法。
• NITRO-SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
  申请人：LABORATORIOS DEL DR. ESTEVE, S.A.

  公开号：EP1851210B1

  公开（公告）日：2011-10-19
• COMBINATION OF A CHOLINESTERASE INHIBITOR AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY
  申请人：Laboratorios Del. Dr. Esteve, S.A.

  公开号：EP2040755A1

  公开（公告）日：2009-04-01